Volumetric and morphological CT parameters for assessing prognosis and the effect of treatment of hepatocellular carcinomas undergoing arterial chemo-embolisation;Volumetrische und morphologische CT-parameter zur prognoseabschatzung und therapiekontrolle des hepatozellularen karzinoms unter arterieller chemoembolisation

RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren

Volumn 167, Issue 3, 1997, Pages 219-226

  Vogl, T J ^a   Trapp, M ^a   Pegios, W ^a   Mack, M ^a   Bechstein, W O ^a   Keck, W ^a   Scholz, A ^a   Schroder H ^a   Neuhaus, P ^a   Felix, R ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Chemo embolisation; Hepatocellular carcinoma

Indexed keywords

CISPLATIN; DOXORUBICIN; IODINATED POPPYSEED OIL; STARCH MICROSPHERE;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; CONTRAST MEDIA; DOXORUBICIN; FEMALE; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; PROGNOSIS; STARCH; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030850464     PISSN: 09366652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bruix, J., A. Castells, X. Motanya, X. Calvet, C. Bru, C. Ayuso, L. Jover, L. Garcia, R. Vilana, L. Boix: Phase II study of transarterial embolisation in European patients with hepatocellular carcinoma: need for controlled trials. Hepatology 20 (1994) 643-650
2. Choi, I., H. C. Kim, J. K. Han, J. H. Park, Y. I. Kim, S. T. Kim, H. S. Lee, C. Y. Kim, M. C. Han: Therapeutic effect of transcatheter oily chemoembolisation for encapsulated nodular hepatocellular carcinoma: CT and pathological findings. Radiology 182 (1992) 709-713
3. Grote, R., E. Schmoll, H. Rosenthal, B. Bokemeyer: Chemoembolisation hepatozellulärer Karzinome - computertomographische Verlaufsbeobachtung. Fortschr. Röntgenstr. 151 (1989) 15-22
4. Gross-Fengels, W., G. Friedmann, M. Kuhn, R. Huber, J. Dommasck, K. F. R. Neufang: Techniken, Ergebnisse und Risiken der Chemoembolisation von malignen Lebertumoren. Akt. Radiol. 1 (1991) 97-104
5. Groupe D'Etude et de Traitement du Carcinoma Hépatocellulaire: A comparison of lipiodol chemoembolisation and conservative treatment for unresectable hepatocellular carcinoma. New Engl. J. Med. 332 (1995) 1256-1261
6. Huppert, P. E., F. Geißler, S. H. Duda, W. Luchart, S. Dette, K. Dietz, H.-J. Brambs, C. D. Claussen: Chemoembolisation des hepatozellulären Karzinoms: Computertomographische Befunde und klinische Resultate bei prospektiv repetitiver Therapie. Fortschr. Röntgenstr. 160 (1994) 425-432
7. Ikeda, K., H. Kumada, S. Saitoh, Y. Arase, K. Chayama: Effect of repeated transcatheter arterial embolisation on the survival time in patients with hepatocellular carcinoma, an analysis by the Cox proportional hazard model. Cancer 68 (1991) 2150-2154
8. Kanematsu, T., T. Matsumata, K. Shirabe, K. Sugimachi, S. Sakamoto, H. Nawata, K. Hasuo, H. Honda, K. Masuada: A comparative study of hepatic resection and transcatheter arterial embolisation for the treatment of primary hepatocellular carcinoma. Cancer 71 (1993) 2181-2186
9. Kawai, S., J. Okamura, M. Ogawa, Y. Ohashi, M. Tani, J. Inoue, Y. Kawarada, M. Kusano, Y. Kubo, C. Kuroda, Y. Sakata, Y. Shimamura, K. Jinno, A. Takahashi, K. Takayasu, K. Tamura, N. Nagasue, Y. Nakanishi, M. Makino, S. Mikuriya, M. Monden, Y. Yumoto, T. Mori, T. Oda, and the Cooperative Study groupe for Liver Cancer Treatment in Japan: Prospective and randomised clinical trial for the treatment of hepatocellular carcinoma - a comparison of Lipiodol-transcatheter arterial embolisation with and without Adriamycin (first cooperative study). Cancer Chemother. Pharmacol. 31 (1992) 1-6
10. Livraghi, T., D. Festi, F. Monti, A. Salmi, C. Vettori: US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 161 (1986) 309-312
11. Monden, M., M. Sakon, M. Gotoh, T. Kanai, K. Uneshita, K. S. Wang, M. Sakurai, C. Kuroda, J. Okamura, T. Mori: Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions. Cancer Chemother. Pharmacol. 31 (1992) 38-44
12. Nakamura, H., T. Tanaka, S. Hori, H. Yoshioka, C. Kuroda, J. Okamura, M. Sakurai: Transcatheter embolisation of hepatocellular carcinoma: Assessment of efficacy in cases of resection following embolisation. Radiology 147 (1983) 401-405
13. Nakamura, H., T. Hashimoto, H. Oi, S. Sawada: Transcatheter oily chemoembolisation of hepatocellular carcinoma. Radiology 170 (1989) 783-786
14. Nakamura, H., T. Mitani, T. Marukami, T. Hashimoto, K. Tsuda, K. Nakanishi: Five-year survival after transcatheter chemoembolisation for hepatocellular carcinoma. Cancer Chemother. Pharmacol. 33 (1994) 89-92
15. Nakao, N., H. Uchida, K. Kamino, Y. Nishimura, H. Ohishi, Y. Takayasu, H. Nakamura, C. Kuroda, M. Fujita, H. Yoshioka, O. Ishida: Effectiveness of Lipiodol in transcatheter arterial embolisation of hepatocellular carcinoma. Cancer Chemother. Pharmacol. 31 (1992) 72-76
16. Nakashima, T., K. Okuda, M. Kojioro, A. Jimi, R. Yamaguchi, K. Sakamoto, T. Ikari: Pathology of hepatocellular carcinoma in Japan, 232 consecutive cases autopsied in ten years. Cancer 51 (1983) 863-877
17. Okamura, J., S. Kawai, M. Ogawa, Y. Ohashi, M. Tani, J. Inoue, Y. Kawarada, M. Kusano, Y. Kubo, C. Kuroda, Y. Sakata, Y. Shimamura, K. Jinno, A. Takahashi, K. Takayasu, K. Tamura, N. Nagasue, Y. Nakanishi, M. Makino, S. Mikuriya, M. Monden, Y. Yumoto, T. Mori, T. Oda, and the Cooperative Study groupe for Liver Cancer Treatment in Japan: Prospective and randomised clinical trial for the treatment of hepatocellular carcinoma - a comparison of L-TAE with Farmorubicin and L-TAE with Adriamycin (second cooperative study). Cancer Chemother. Pharmacol. 31 (1992) 20-24 und ebd. 33 (1994) 97-102
18. Okamura, J., S. Kawai, M. Ogawa, Y. Ohashi, M. Tani, J. Inoue, Y. Kawarada, M. Kusano, Y. Kubo, C. Kuroda, Y. Sakata, Y. Shimamura, K. Jinno, A. Takahashi, K. Takayasu, K. Tamura, N. Nagasue, Y. Nakanishi, M. Makino, S. Mikuriya, M. Monden, Y. Yumoto, T. Mori, T. Oda, and the Cooperative Study groupe for Liver Cancer Treatment in Japan: Prospective and randomised clinical trial for the treatment of hepatocellular carcinoma - a comparison of L- TAE with Farmorubicin and L-TAE with Adriamycin (second cooperative study). Cancer Chemother. Pharmacol. 31 (1992) 20-24 und ebd. 33 (1994) 97-102
19. Okuda, K., T. Ohtsuki, H. Obata, M. Tomimatsu, N. Okazaki, H. Hasegawa, Y. Nakajima, K. Ohnishi: Natural history of hepatocellular carcinoma and prognosis in relation to treatment, study of 850 patients. Cancer 56 (1985) 918-928
20. Okuda, K., R. L. Peters, I. W. Simson: Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Cancer 54 (1984) 2165-2173
21. Pirschel, J., W. Lauchart: Chemoembolisation primärer Leberzellkarzinome mit Epirubicin-Lipiodol. Fortschr. Röntgenstr. 155 (1991) 409-415
22. Raoul, J. L., D. Heresbach, J. F. Bretagne, D. Bentue Ferrer, R. Duvauferrier, P. Bourguet, M. Messner, M. Gosselin: Chemoembolisation of hepatocellular carcinomas. Cancer 70 (1992) 585-590
23. Scholz, A., M. Langer, R. Langer, R. Felix, P. Neuhaus: Intraarterielle Chemoembolisation nicht-resektabler hepatozellulärer Karzinome. Fortschr. Röntgenstr. 154 (1991) 258-261
24. Sevastano, S., L. Benvegnu, G. P. Feltrin, A. Alberti, M. Chiesura-Corona, D. Miotto: Transcatheter arterial embolisation versus no treatment in cirrhotic patients with hepatocellular carcinoma: a retrospective comparative study. Eur. Radiol. 4 (1994) 1-6
25. Shibata, J., S. Fujiyama, T. Sato, S. Kishimoto, S. Fukushima, M. Nakamo: Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma. Cancer 64 (1989) 1586-1594
26. Shiina, S., K. Tawaga, T. Unuma, R. Takanashi, K. Yoshiura, Y. Komatsu, Y. Hata, Y. Niwa, Y. Shiratori, A. Terano, T. Sugimoto: Percutaneous ethanol injection therapy for hepatocellular carcinoma, a histopathological study. Cancer 68 (1991) 1524-1530
27. Takayasu, K., F. Wakao, N. Moriyama, S. Yamazaki, T. Kosuge, T. Takeyama, S. Okada, N. Okazaki, M. Makuuchi: Postresection recurrence of hepatocellular carcinoma treated by arterial embolisation: an analysis of prognostic factors. Hepatology 16 (1992) 906-911
28. Tanaka, K., H. Okazaki, S. Nakamura, O. Endo, S. Inoue, Y. Takamura, M. Sugiyama, Y. Ohaki: Hepatocellular carcinoma: treatment with a combination therapy of transcatheter arterial embolisation and percutaneous ethanol injection. Radiology 179 (1991) 713-717
29. Taniquchi, K., K. Nakato, Y. Kato, Y. Sato, K. Hamasaki, S. Tsuruta, S. Nakataki: Treatment of hepatocellular carcinoma with transcatheter arterial embolisation. Analysis of prognostic factors. Cancer 73 (1994) 1341-1345
30. Witte, G., B. Kremer, D. Henne-Bruns, A. Jordan, E. Bücheler: Chemoembolisation bei primärem Leberzellkarzinom. Fortschr. Röntgenstr. 154 (1991) 634-637
31. Yamamoto, K., M. Masuzawa, M. Kato, T. Okuyama, K. Tamura: Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolisation. Cancer Chemother. Pharmacol. 31 (1992) 77-81
32. Yamashita, Y., M. Takahashi, Y. Koga, R. Saito, S. Nanakawa, Y. Hatanaka, N. Sato, K. Nakashima, J. Urata, K. Yoshizumi, K. Ito, S. Sumi, M. Kan: Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolisation and arterial infusion. Cancer 67 (1991) 385-391
33. Wickenhöfer, R., I. Hasan, H. Schüller, M. Reiser, J. H. Hartlapp: Ergebnisse der Chemoembolisation fortgeschrittener Leberzellkarzinome. Einfluß auf Überlebenszeiten, morphologische Befunde und Tumormarker. Fortschr. Röntgenstr. 156 (1992) 328-332